PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 20261 citations

Anticoagulation Practices Surrounding Emergency Department Cardioversion for Atrial Fibrillation and Flutter.

View Full Paper
TMThomas MaourisRoyal Brisbane and Women's HospitalPMPeter Del MarRoyal Brisbane and Women's HospitalNBNathan J. BrownRoyal Women's Hospital

Key Result

Most patients undergoing ED cardioversion received guideline-concordant anticoagulation, but dosing variability and follow-up gaps remain, especially in low-risk patients.

Key Points

  • The research aims to evaluate anticoagulation practices during emergency department (ED) cardioversion for atrial fibrillation and flutter.
  • Analyzed anticoagulation practices in patients undergoing ED cardioversion.
  • Identified variability in dosing and post-procedural therapy among patients.
  • Examined follow-up care and continuity of anticoagulation for low-risk patients.
  • Most patients received guideline-concordant anticoagulation prior to cardioversion.
  • Notable variability in dosing and therapy was observed, especially among low-risk patients.
  • High revisit rates underscore the need for better follow-up and structured care pathways.

Structured PICO

P
Population
Patients undergoing emergency department cardioversion for atrial fibrillation and flutter
O
Outcome
Guideline-concordant anticoagulation, dosing variability, and revisit rates

While most ED cardioversion patients receive guideline-concordant anticoagulation, variability in post-procedural care and high revisit rates indicate a need for structured follow-up pathways.

Abstract

Most patients undergoing ED cardioversion received guideline-concordant anticoagulation. However, variability in dosing and post-procedural therapy persists, particularly among low-risk patients. High revisit rates highlight the need for improved follow-up, continuity of anticoagulation, and structured care pathways following ED cardioversion.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Maouris et al. (2026) studied this question. Most patients undergoing ED cardioversion received guideline-concordant anticoagulation, but dosing variability and follow-up gaps remain, especially in low-risk patients.

synapsesocial.com/papers/69a7ccb2d48f933b5eed86f5https://doi.org/10.1111/1742-6723.70231
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardioversion of Atrial Arrhythmias: Audit of Anticoagulation Management1997 · 8 citations
  2. 2Advances in anticoagulation management of patients undergoing cardioversion of nonvalvular atrial fibrillation2017 · 3 citations
  3. 3Prevention of Embolic Events After Cardioversion of Atrial Fibrillation1995 · 56 citations
  4. 4Thirty‐day Outcomes of Emergency Department Patients Undergoing Electrical Cardioversion for Atrial Fibrillation or Flutter2010 · 66 citations
  5. 5Cardioversion of recent-onset atrial fibrillation and flutter in the emergency department2014